Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 948

1.

p16 status and choice of chemotherapy in the KEYNOTE-040 study - Authors' reply.

Cohen EEW, Soulières D, Swaby RF, Harrington KJ.

Lancet. 2019 Oct 12;394(10206):1323. doi: 10.1016/S0140-6736(19)31264-4. No abstract available.

PMID:
31609223
2.

Opioid agonist therapy during residential treatment of opioid use disorder: Cohort study on access and outcomes.

Spithoff S, Meaney C, Urbanoski K, Harrington K, Que B, Kahan M, Leece P, Shehadeh V, Sullivan F.

Can Fam Physician. 2019 Oct;65(10):e443-e452.

PMID:
31604755
3.

Optimal acquisition scheme for flow-compensated intravoxel incoherent motion diffusion-weighted imaging in the abdomen: An accurate and precise clinically feasible protocol.

Gurney-Champion OJ, Rauh SS, Harrington K, Oelfke U, Laun FB, Wetscherek A.

Magn Reson Med. 2019 Sep 30. doi: 10.1002/mrm.27990. [Epub ahead of print]

PMID:
31566262
4.

A large pool of actively cycling progenitors orchestrates self-renewal and injury repair of an ectodermal appendage.

Sharir A, Marangoni P, Zilionis R, Wan M, Wald T, Hu JK, Kawaguchi K, Castillo-Azofeifa D, Epstein L, Harrington K, Pagella P, Mitsiadis T, Siebel CW, Klein AM, Klein OD.

Nat Cell Biol. 2019 Sep;21(9):1102-1112. doi: 10.1038/s41556-019-0378-2. Epub 2019 Sep 2.

PMID:
31481792
5.

Feel the noise: Mid-air ultrasound haptics as a novel human-vehicle interaction paradigm.

Large DR, Harrington K, Burnett G, Georgiou O.

Appl Ergon. 2019 Nov;81:102909. doi: 10.1016/j.apergo.2019.102909. Epub 2019 Jul 26.

PMID:
31422270
6.

Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age.

Saba NF, Blumenschein G Jr, Guigay J, Licitra L, Fayette J, Harrington KJ, Kiyota N, Gillison ML, Ferris RL, Jayaprakash V, Li L, Brossart P.

Oral Oncol. 2019 Sep;96:7-14. doi: 10.1016/j.oraloncology.2019.06.017. Epub 2019 Jul 3.

7.

Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.

Thomas S, Kuncheria L, Roulstone V, Kyula JN, Mansfield D, Bommareddy PK, Smith H, Kaufman HL, Harrington KJ, Coffin RS.

J Immunother Cancer. 2019 Aug 10;7(1):214. doi: 10.1186/s40425-019-0682-1.

8.

Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome.

Dowd RS, Nail TJ, Arkun K, Kryzanski J, Soto O, Fogaren T, Harrington K, Patel A, Comenzo R, Riesenburger RI.

World Neurosurg. 2019 Jul 29;131:104-107. doi: 10.1016/j.wneu.2019.07.172. [Epub ahead of print]

PMID:
31369882
9.

Cohort profile: Extended Cohort for E-health, Environment and DNA (EXCEED).

John C, Reeve NF, Free RC, Williams AT, Ntalla I, Farmaki AE, Bethea J, Barton LM, Shrine N, Batini C, Packer R, Terry S, Hargadon B, Wang Q, Melbourne CA, Adams EL, Bee CE, Harrington K, Miola J, Brunskill NJ, Brightling CE, Barwell J, Wallace SE, Hsu R, Shepherd DJ, Hollox EJ, Wain LV, Tobin MD.

Int J Epidemiol. 2019 Jul 31. pii: dyz175. doi: 10.1093/ije/dyz175. [Epub ahead of print] No abstract available.

PMID:
31365084
10.

Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veterans.

Gelernter J, Sun N, Polimanti R, Pietrzak R, Levey DF, Bryois J, Lu Q, Hu Y, Li B, Radhakrishnan K, Aslan M, Cheung KH, Li Y, Rajeevan N, Sayward F, Harrington K, Chen Q, Cho K, Pyarajan S, Sullivan PF, Quaden R, Shi Y, Hunter-Zinck H, Gaziano JM, Concato J, Zhao H, Stein MB; Department of Veterans Affairs Cooperative Studies Program (#575B) and Million Veteran Program.

Nat Neurosci. 2019 Sep;22(9):1394-1401. doi: 10.1038/s41593-019-0447-7. Epub 2019 Jul 29.

PMID:
31358989
11.

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).

Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL.

J Immunother Cancer. 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5.

12.

Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring.

Van Name MA, Miller KM, Commissariat PV, Whitehouse AL, Harrington KR, Anderson BJ, Mantravadi MG, Levy W, DeSalvo DJ, Tamborlane WV, Hilliard ME, Laffel LM, DiMeglio LA.

Diabet Med. 2019 Jul 11. doi: 10.1111/dme.14074. [Epub ahead of print] No abstract available.

PMID:
31295359
13.

Optimizing oncolytic virotherapy in cancer treatment.

Harrington K, Freeman DJ, Kelly B, Harper J, Soria JC.

Nat Rev Drug Discov. 2019 Sep;18(9):689-706. doi: 10.1038/s41573-019-0029-0. Epub 2019 Jul 10. Review.

PMID:
31292532
14.

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes.

Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA.

Diabetes Technol Ther. 2019 Sep;21(9):493-498. doi: 10.1089/dia.2019.0142. Epub 2019 Jul 9.

PMID:
31287721
15.

International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma.

Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):567-580. doi: 10.1016/j.ijrobp.2019.06.2540. Epub 2019 Jul 2.

PMID:
31276776
16.

Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer.

Annels NE, Mansfield D, Arif M, Ballesteros-Merino C, Simpson GR, Denyer M, Sandhu SS, Melcher AA, Harrington KJ, Davies B, Au G, Grose M, Bagwan I, Fox B, Vile R, Mostafid H, Shafren D, Pandha HS.

Clin Cancer Res. 2019 Oct 1;25(19):5818-5831. doi: 10.1158/1078-0432.CCR-18-4022. Epub 2019 Jul 4.

PMID:
31273010
17.

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21.

Müller LME, Holmes M, Michael JL, Scott GB, West EJ, Scott KJ, Parrish C, Hall K, Stäble S, Jennings VA, Cullen M, McConnell S, Langton C, Tidswell EL, Shafren D, Samson A, Harrington KJ, Pandha H, Ralph C, Kelly RJ, Cook G, Melcher AA, Errington-Mais F.

J Immunother Cancer. 2019 Jul 1;7(1):164. doi: 10.1186/s40425-019-0632-y.

18.

Gender Differences in Demographic and Health Characteristics of the Million Veteran Program Cohort.

Harrington KM, Nguyen XT, Song RJ, Hannagan K, Quaden R, Gagnon DR, Cho K, Deen JE, Muralidhar S, O'Leary TJ, Gaziano JM, Whitbourne SB; VA Million Veteran Program.

Womens Health Issues. 2019 Jun 25;29 Suppl 1:S56-S66. doi: 10.1016/j.whi.2019.04.012.

PMID:
31253243
19.

Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.

Haddad R, Concha-Benavente F, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Kasper S, Vokes EE, Worden F, Saba NF, Tahara M, Jayaprakash V, Lynch M, Li L, Gillison ML, Harrington KJ, Ferris RL.

Cancer. 2019 Sep 15;125(18):3208-3218. doi: 10.1002/cncr.32190. Epub 2019 Jun 27.

20.

Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use.

Ferris RL, Licitra L, Fayette J, Even C, Blumenschein G Jr, Harrington KJ, Guigay J, Vokes EE, Saba NF, Haddad R, Ramkumar S, Russell J, Brossart P, Tahara M, Colevas AD, Concha-Benavente F, Lynch M, Li L, Gillison ML.

Clin Cancer Res. 2019 Sep 1;25(17):5221-5230. doi: 10.1158/1078-0432.CCR-18-3944. Epub 2019 Jun 25.

PMID:
31239321
21.

High Yield of Active Tuberculosis Case Finding Among HIV-Infected Patients Using Xpert MTB/RIF Testing.

Kempker RR, Chkhartishvili N, Kinkladze I, Schechter MC, Harrington K, Rukhadze N, Dzigua L, Tserstvadze T, Del Rio C, Blumberg HM, Tukvadze N.

Open Forum Infect Dis. 2019 May 17;6(6):ofz233. doi: 10.1093/ofid/ofz233. eCollection 2019 Jun.

22.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1146. [Epub ahead of print]

PMID:
31194247
23.

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma.

Andtbacka RHI, Collichio F, Harrington KJ, Middleton MR, Downey G, Ӧhrling K, Kaufman HL.

J Immunother Cancer. 2019 Jun 6;7(1):145. doi: 10.1186/s40425-019-0623-z.

24.

Genome-wide Association Study of Maximum Habitual Alcohol Intake in >140,000 U.S. European and African American Veterans Yields Novel Risk Loci.

Gelernter J, Sun N, Polimanti R, Pietrzak RH, Levey DF, Lu Q, Hu Y, Li B, Radhakrishnan K, Aslan M, Cheung KH, Li Y, Rajeevan N, Sayward F, Harrington K, Chen Q, Cho K, Honerlaw J, Pyarajan S, Lencz T, Quaden R, Shi Y, Hunter-Zinck H, Gaziano JM, Kranzler HR, Concato J, Zhao H, Stein MB; Department of Veterans Affairs Cooperative Studies Program (No. 575B); Million Veteran Program.

Biol Psychiatry. 2019 Sep 1;86(5):365-376. doi: 10.1016/j.biopsych.2019.03.984. Epub 2019 Apr 8.

PMID:
31151762
25.

Low cost 235 nm ultra-violet light-emitting diode-based absorbance detector for application in a portable ion chromatography system for nitrite and nitrate monitoring.

Murray E, Roche P, Harrington K, McCaul M, Moore B, Morrin A, Diamond D, Paull B.

J Chromatogr A. 2019 Oct 11;1603:8-14. doi: 10.1016/j.chroma.2019.05.036. Epub 2019 May 21.

PMID:
31151694
26.

High fidelity fibre-based physiological sensing deep in tissue.

Choudhary TR, Tanner MG, Megia-Fernandez A, Harrington K, Wood HA, Marshall A, Zhu P, Chankeshwara SV, Choudhury D, Monro G, Ucuncu M, Yu F, Duncan RR, Thomson RR, Dhaliwal K, Bradley M.

Sci Rep. 2019 May 22;9(1):7713. doi: 10.1038/s41598-019-44077-7.

27.

Determinants of cigarette smoking status in a national cohort of black and white adult ever smokers in the USA: a cross-sectional analysis of the REGARDS study.

Parekh TM, Wu C, McClure LA, Howard VJ, Cushman M, Malek AM, Harrington KF, Cherrington AL, Dransfield MT, Bhatia S.

BMJ Open. 2019 May 10;9(5):e027175. doi: 10.1136/bmjopen-2018-027175.

28.

Cohort Profile: Extended Cohort for E-health, Environment and DNA (EXCEED).

John C, Reeve NF, Free RC, Williams AT, Ntalla I, Farmaki AE, Bethea J, Barton LM, Shrine N, Batini C, Packer R, Terry S, Hargadon B, Wang Q, Melbourne CA, Adams EL, Bee CE, Harrington K, Miola J, Brunskill NJ, Brightling CE, Barwell J, Wallace SE, Hsu R, Shepherd DJ, Hollox EJ, Wain LV, Tobin MD.

Int J Epidemiol. 2019 Jun 1;48(3):678-679j. doi: 10.1093/ije/dyz073. No abstract available.

29.

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition.

Jennings VA, Scott GB, Rose AMS, Scott KJ, Migneco G, Keller B, Reilly K, Donnelly O, Peach H, Dewar D, Harrington KJ, Pandha H, Samson A, Vile RG, Melcher AA, Errington-Mais F.

Mol Ther. 2019 Jun 5;27(6):1139-1152. doi: 10.1016/j.ymthe.2019.04.008. Epub 2019 Apr 14.

30.

Validation of an Electronic Medical Record-Based Algorithm for Identifying Posttraumatic Stress Disorder in U.S. Veterans.

Harrington KM, Quaden R, Stein MB, Honerlaw JP, Cissell S, Pietrzak RH, Zhao H, Radhakrishnan K, Aslan M, Gaziano JM, Concato J, Gagnon DR, Gelernter J, Cho K; VA Million Veteran Program and Cooperative Studies Program.

J Trauma Stress. 2019 Apr;32(2):226-237. doi: 10.1002/jts.22399.

PMID:
31009556
31.

Principal component analysis fosr fast and model-free denoising of multi b-value diffusion-weighted MR images.

Gurney-Champion OJ, Collins DJ, Wetscherek A, Rata M, Klaassen R, van Laarhoven HWM, Harrington KJ, Oelfke U, Orton MR.

Phys Med Biol. 2019 May 17;64(10):105015. doi: 10.1088/1361-6560/ab1786.

PMID:
30965296
32.

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment.

Evgin L, Huff AL, Kottke T, Thompson J, Molan AM, Driscoll CB, Schuelke M, Shim KG, Wongthida P, Ilett EJ, Smith KK, Harris RS, Coffey M, Pulido JS, Pandha H, Selby PJ, Harrington KJ, Melcher A, Vile RG.

Cancer Immunol Res. 2019 May;7(5):828-840. doi: 10.1158/2326-6066.CIR-18-0013. Epub 2019 Apr 2.

PMID:
30940643
33.

Escalation of Memory Length in Finite Populations.

Harrington K, Pollack J.

Artif Life. 2019 Winter;25(1):22-32. doi: 10.1162/artl_a_00278.

PMID:
30933630
34.

Use of Patient-Reported Outcome Measures in Athletic Training: Common Measures, Selection Considerations, and Practical Barriers.

Lam KC, Harrington KM, Cameron KL, Valier ARS.

J Athl Train. 2019 Apr;54(4):449-458. doi: 10.4085/1062-6050-108-17. Epub 2019 Apr 1.

PMID:
30933607
35.

Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.

Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P for the AIBL Research Group.

J Clin Exp Neuropsychol. 2019 Aug;41(6):591-600. doi: 10.1080/13803395.2019.1593949. Epub 2019 Mar 29.

PMID:
30924399
36.

GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.

Smith EL, Harrington K, Staehr M, Masakayan R, Jones J, Long TJ, Ng KY, Ghoddusi M, Purdon TJ, Wang X, Do T, Pham MT, Brown JM, De Larrea CF, Olson E, Peguero E, Wang P, Liu H, Xu Y, Garrett-Thomson SC, Almo SC, Wendel HG, Riviere I, Liu C, Sather B, Brentjens RJ.

Sci Transl Med. 2019 Mar 27;11(485). pii: eaau7746. doi: 10.1126/scitranslmed.aau7746.

PMID:
30918115
37.

Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations.

Yavuz B, Zeki J, Taylor J, Harrington K, Coburn JM, Ikegaki N, Kaplan DL, Chiu B.

J Pharm Sci. 2019 Aug;108(8):2748-2755. doi: 10.1016/j.xphs.2019.03.019. Epub 2019 Mar 21.

PMID:
30905702
38.

Improving Attitudes and Perceptions About End-of-Life Nursing on a Hospital-Based Palliative Care Unit.

Harrington KJ, Affronti ML, Schneider SM, Razzak AR, Smith TJ.

J Hosp Palliat Nurs. 2019 Aug;21(4):272-279. doi: 10.1097/NJH.0000000000000523.

PMID:
30893285
39.

PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma.

Smith HG, Mansfield D, Roulstone V, Kyula-Currie JN, McLaughlin M, Patel RR, Bergerhoff KF, Paget JT, Dillon MT, Khan A, Melcher A, Thway K, Harrington KJ, Hayes AJ.

Clin Cancer Res. 2019 Jun 1;25(11):3443-3454. doi: 10.1158/1078-0432.CCR-18-3767. Epub 2019 Mar 18.

PMID:
30885937
40.

Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention.

Yavuz B, Morgan JL, Herrera C, Harrington K, Perez-Ramirez B, LiWang PJ, Kaplan DL.

J Control Release. 2019 May 10;301:1-12. doi: 10.1016/j.jconrel.2019.03.001. Epub 2019 Mar 12.

PMID:
30876951
41.

Radiotherapy enhances responses of lung cancer to CTLA-4 blockade.

Wilkins A, McDonald F, Harrington K, Melcher A.

J Immunother Cancer. 2019 Mar 6;7(1):64. doi: 10.1186/s40425-019-0542-z.

42.

Multi-sample SPIM image acquisition, processing and analysis of vascular growth in zebrafish.

Daetwyler S, Günther U, Modes CD, Harrington K, Huisken J.

Development. 2019 Mar 21;146(6). pii: dev173757. doi: 10.1242/dev.173757.

43.

Quality Improvement Project to Improve Screening for Tobacco Use in Adolescent Inpatients at a Children's Hospital.

Wagner LA, Molina AL, Grizzle K, Hofto ME, Nassetta LB, Orr MM, Samuy N, Schmit EO, Smola C, Harrington KF, Walley SC.

Children (Basel). 2019 Feb 28;6(3). pii: E37. doi: 10.3390/children6030037.

44.

Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial.

Moy ML, Harrington KF, Sternberg AL, Krishnan JA, Albert RK, Au DH, Casaburi R, Criner GJ, Diaz P, Kanner RE, Panos RJ, Stibolt T, Stoller JK, Tonascia J, Yusen RD, Tan AM, Fuhlbrigge AL; LOTT Research Group.

Respir Med. 2019 Mar;149:52-58. doi: 10.1016/j.rmed.2019.02.004. Epub 2019 Feb 13.

PMID:
30803886
45.

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment.

Dillon MT, Bergerhoff KF, Pedersen M, Whittock H, Crespo-Rodriguez E, Patin EC, Pearson A, Smith HG, Paget JTE, Patel RR, Foo S, Bozhanova G, Ragulan C, Fontana E, Desai K, Wilkins AC, Sadanandam A, Melcher A, McLaughlin M, Harrington KJ.

Clin Cancer Res. 2019 Jun 1;25(11):3392-3403. doi: 10.1158/1078-0432.CCR-18-1821. Epub 2019 Feb 15.

PMID:
30770349
46.

Genomics of posttraumatic stress disorder in veterans: Methods and rationale for Veterans Affairs Cooperative Study #575B.

Radhakrishnan K, Aslan M, Harrington KM, Pietrzak RH, Huang G, Muralidhar S, Cho K, Quaden R, Gagnon D, Pyarajan S, Sun N, Zhao H, Gaziano M, Concato J, Stein MB, Gelernter J.

Int J Methods Psychiatr Res. 2019 Mar;28(1):e1767. doi: 10.1002/mpr.1767. Epub 2019 Feb 14.

PMID:
30767326
47.

Effect on herbicide adsorption of organic forestry waste products used for soil remediation.

James TK, Ghanizadeh H, Harrington KC, Bolan NS.

J Environ Sci Health B. 2019;54(5):407-415. doi: 10.1080/03601234.2019.1574170. Epub 2019 Feb 7.

PMID:
30729862
48.

Hospital Onset Varicella Central Nervous System Vasculitis in a Patient with HIV Infection.

Harrington KRV, Rhyner P, Kempker RR.

AIDS Res Hum Retroviruses. 2019 Apr;35(4):357-358. doi: 10.1089/aid.2018.0262. Epub 2019 Feb 4. No abstract available.

PMID:
30715900
49.

Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe.

Gutzmer R, Harrington KJ, Hoeller C, Lebbé C, Malvehy J, Öhrling K, Downey G, Dummer R.

Eur J Dermatol. 2018 Dec 1;28(6):736-749. doi: 10.1684/ejd.2018.3447. Review.

PMID:
30698145
50.

Artificial Gene Regulatory Networks-A Review.

Cussat-Blanc S, Harrington K, Banzhaf W.

Artif Life. 2018 Fall;24(4):296-328. doi: 10.1162/artl_a_00267. Epub 2019 Jan 25. Review.

PMID:
30681915

Supplemental Content

Loading ...
Support Center